オープン アクセスを義務付けられた論文 - Tanja D. de Gruijl詳細
一般には非公開: 9 件
Bispecific antibody platforms for cancer immunotherapy
R Lameris, RCG de Bruin, FL Schneiders, PMPB en Henegouwen, ...
Critical reviews in oncology/hematology 92 (3), 153-165, 2014
委任: Worldwide Cancer Research, UK, Netherlands Organisation for Health Research …
Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle
T Wurdinger, K Deumelandt, HJ van der Vliet, P Wesseling, TD de Gruijl
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 560-575, 2014
委任: European Commission, Netherlands Organisation for Health Research and …
Immune-competent human skin disease models
LIJC Bergers, CMA Reijnders, LJ van den Broek, SW Spiekstra, ...
Drug discovery today 21 (9), 1479-1488, 2016
委任: Netherlands Organisation for Health Research and Development
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell …
J Rotman, AM Heeren, AA Gassama, SM Lougheed, N Pocorni, ...
Clinical Cancer Research 26 (14), 3791-3802, 2020
委任: Dutch Cancer Society
Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells
S Duinkerken, RE Li, FJ van Haften, TD de Gruijl, F Chiodo, STT Schetters, ...
Current Opinion in Chemical Biology 53, 167-172, 2019
委任: European Commission
Inactivating PSMB5 mutations and P-glycoprotein (MDR1/ABCB1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno) proteasome inhibitors in mononuclear …
SE Verbrugge, YG Assaraf, BAC Dijkmans, GL Scheffer, M Al, D den Uyl, ...
Journal of Pharmacology and Experimental Therapeutics, 2012
委任: Royal Netherlands Academy of Arts and Sciences
The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer
FL Schneiders, CM Huijts, M Reijm, HJ Bontkes, HMW Verheul, ...
Immunobiology 223 (2), 171-177, 2018
委任: Netherlands Organisation for Health Research and Development, Dutch Cancer …
Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells
FL Schneiders, CM Huijts, A Mantici, MAC Menks, E Scotet, R Veerhuis, ...
Clinical Immunology 158 (1), 92-99, 2015
委任: Netherlands Organisation for Health Research and Development, Dutch Cancer …
Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival
FEF Timmer, B Geboers, HJ Scheffer, J Bakker, AH Ruarus, M Dijkstra, ...
Journal of vascular and interventional radiology 34 (10), 1777-1784. e4, 2023
委任: Dutch Cancer Society, Melanoma Research Alliance
一般公開: 109 件
Functional delivery of viral miRNAs via exosomes
DM Pegtel, K Cosmopoulos, DA Thorley-Lawson, MAJ van Eijndhoven, ...
Proceedings of the National Academy of Sciences 107 (14), 6328-6333, 2010
委任: US National Institutes of Health
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
AM Heeren, S Punt, MCG Bleeker, KN Gaarenstroom, J Van Der Velden, ...
Modern Pathology 29 (7), 753-763, 2016
委任: Dutch Cancer Society
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ...
BMC cancer 19, 1-15, 2019
委任: Ontario Institute for Cancer Research
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
SJAM Santegoets, EM Dijkgraaf, A Battaglia, P Beckhove, CM Britten, ...
Cancer Immunology, Immunotherapy 64, 1271-1286, 2015
委任: US National Institutes of Health, German Research Foundation, Cancer …
Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II feasibility trial (PERFECT)
T Van Den Ende, NC De Clercq, MI van Berge Henegouwen, SS Gisbertz, ...
Clinical Cancer Research 27 (12), 3351-3359, 2021
委任: Dutch Cancer Society
The rise of allogeneic natural killer cells as a platform for cancer immunotherapy: recent innovations and future developments
JP Veluchamy, N Kok, HJ van der Vliet, HMW Verheul, TD de Gruijl, ...
Frontiers in immunology 8, 631, 2017
委任: European Commission
Defining the critical hurdles in cancer immunotherapy
BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ...
Journal of translational medicine 9, 1-15, 2011
委任: US National Institutes of Health
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression
SR Baglio, T Lagerweij, M Pérez-Lanzón, XD Ho, N Léveillé, SA Melo, ...
Clinical Cancer Research 23 (14), 3721-3733, 2017
委任: European Commission, Dutch Cancer Society
Sensing of latent EBV infection through exosomal transfer of 5′ pppRNA
SR Baglio, MAJ van Eijndhoven, D Koppers-Lalic, J Berenguer, ...
Proceedings of the National Academy of Sciences 113 (5), E587-E596, 2016
委任: Netherlands Organisation for Scientific Research, Worldwide Cancer Research …
High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from …
AM Heeren, BD Koster, S Samuels, DM Ferns, D Chondronasiou, ...
Cancer immunology research 3 (1), 48-58, 2015
委任: Dutch Cancer Society
Transcriptional profiling of human dendritic cell populations and models-unique profiles of in vitro dendritic cells and implications on functionality and applicability
K Lundberg, AS Albrekt, I Nelissen, S Santegoets, TD de Gruijl, S Gibbs, ...
PloS one 8 (1), e52875, 2013
委任: Swedish Research Council
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます